Alexandria Real Estate Equities Inc (ARE) is a dominant franchise in the life science real estate sector, but the market has undervalued the company due to a misunderstanding of its assets. Despite recent challenges, the company is well-positioned for a powerful recovery cycle, with stable leasing spreads, strong occupancy rates, and a strengthened balance sheet. The equity represents a compelling opportunity for aggressive investors, with the potential for the gap between share price and intrinsic value to close in 2026. The recent dividend cut only serves to reinforce the company’s financial strength.

Read more at Barchart: Alexandria Real Estate Equities Inc. (ARE)